Kristen Hege - Researcher Profile | RDL Research Database

Publications

3 shown

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Alfons JM van den Eertwegh , Jurjen Versluis , H. Pieter van den Berg +15 more

2012 The Lancet Oncology 355 citations

Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

Nikhil C. Munshi , Larry D. Anderson , Nina Shah +25 more

Ide-cel induced responses in a majority of heavily pretreated patients with refractory and relapsed myeloma; MRD-negative status was achieved in 26% of treated patients. Almost ...

2021 New England Journal of Medicine 2137 citations

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Noopur Raje , Jesús G. Berdeja , Yi Lin +20 more

We report the initial toxicity profile of a BCMA-directed cellular immunotherapy for patients with relapsed or refractory multiple myeloma. Antitumor activity was documented. (F...

2019 New England Journal of Medicine 1641 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 4,133
Institution: Genesys (United States)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-9609-5029

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.